Irving W. Bailit, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 230 Worcester St, Wellesley, MA 02481 Phone: 781-431-5435 |
News Archive
The Viennese biotech company Affiris is today taking stock of the progress achieved to date in its clinical Alzheimer's vaccination programme. All the Alzheimer's patients treated so far as part of the toxicological trials have tolerated the treatment extremely well. As a result, Affiris is among the leading international centres in the race to develop the first causal immunotherapy for Alzheimer's disease.
Bristol-Myers Squibb Company and Gilead Sciences, Inc. today announced a licensing agreement for Bristol-Myers Squibb to develop and commercialize a fixed-dose combination containing Bristol-Myers Squibb's protease inhibitor REYATAZ (atazanavir sulfate) and Gilead's cobicistat, a pharmacoenhancing or "boosting" agent that increases blood levels of certain HIV medicines to potentially allow for one pill once daily dosing.
Weight loss, as well as maintaining a healthy weight, is a challenge that can sometimes seem insurmountable.
Elanco Animal Health, a division of Eli Lilly and Company, in collaboration with Purdue University's College of Veterinary Medicine, today released preliminary research findings that support the power of the human-animal bond.
› Verified 7 days ago